PolarCool AB (publ) (NGM:POLAR)

Market Cap	18.13M -34.7%
Revenue (ttm)	2.82M +19.1%
Net Income	-17.74M
EPS	-2.50
Shares Out	11.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,727
Open	1.640
Previous Close	1.740
Day's Range	1.490 - 1.640
52-Week Range	0.955 - 5.500
Beta	0.59
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About PolarCool AB

PolarCool AB (publ.) is a medical technology company that develops, markets and sells sports medicine products. It focuses on the treatment of concussions and repetitive head impacts with its primary product, the concussion treatment PolarCap. It serves teams, organizations, and athletes. PolarCool AB (publ) was incorporated in 2017 and is based in Lund, Sweden.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2017
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: POLAR

Financial Performance

In 2025, PolarCool AB's revenue was 2.40 million, an increase of 15.05% compared to the previous year's 2.08 million. Losses were -16.73 million, 51.7% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 30, 2026

Data Sources Report a data error